🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "specific action to deal with cost of living challenges" in the upcoming financial statement.

In comments to media outlets, she noted that lowering inflation is a collective duty of both the government and the central bank.

The UK's price growth is forecast to be the most elevated among the G7 developed nations this year and the following year.

Possible Utility Bill Measures

It is understood the administration could take action to bring down utility costs, such as by slashing the current 5% rate of VAT charged on energy.

An additional approach is to cut some of the regulatory levies presently added to household expenses.

Budgetary Limitations and Analyst Expectations

The administration will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for such measures.

The view from most economists is that the Chancellor will have to introduce tax rises or spending cuts in order to adhere to her self-imposed fiscal targets.

Earlier on the same day, estimates showed there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the lower end of expectations.

"It is a collective task between the central bank and the government to bear down further on some of the causes of price increases," Reeves stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While a great deal of the focus has been on likely tax increases, the Treasury chief said the most recent information from the fiscal watchdog had not altered her commitment to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing international and trade concerns for the Budget tax moves, probably to be focused on those "with the broadest shoulders."

Global Trade Disputes

Commenting on worries about the United Kingdom's economic relations with China she said: "Our national security always are paramount."

Last week's announcement by Chinese authorities to increase trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to suggest an further 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two economic giants.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a international production control attempt."

Inquired about considering the US offer to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and generates additional obstacles."

"I believe there are fields where we should address Chinese policies, but there are also valuable chances to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to get that balance appropriate."

The Treasury chief also stated she was collaborating with G7 counterparts "on our own critical minerals plan, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service spends on medicines could increase as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or scrapping projects in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the cost the health service spends on medicines would need to rise to halt firms and pharmaceutical investment leaving the UK.

Reeves told the BBC: "It has been observed because of the pricing regime, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other EU nations."

"The objective is to ensure that patients receiving treatment from the National Health Service are can receive the best critical drugs in the globe. And so we are looking at all of that, and... aiming to attract increased capital into the UK."